Literature DB >> 21906833

A novel explant outgrowth culture model for mouse pancreatic acinar cells with long-term maintenance of secretory phenotype.

Merja Bläuer1, Isto Nordback, Juhani Sand, Johanna Laukkarinen.   

Abstract

The development of in vitro models able to support the long-term viability and function of acinar cells is critical for exploring pancreatic pathophysiology. Despite considerable efforts, no long-term culture models for non-transformed pancreatic acini exist. Our aim was to develop and validate culture conditions for this purpose. An explant outgrowth culture design was established in which mouse pancreatic explants were cultured at the gas-liquid interphase. An enriched culture medium, pH 7.8, was employed to promote the selective outgrowth of acinar cells and to support their differentiated phenotype. After 7 days, the outgrown primary acinar cells were subcultured and maintained up to an additional 7 days as secondary monolayers on tissue culture plastic. Measurements of basal and caerulein-induced amylase secretion, phase-contrast microscopy and immunohistochemical analyses were used to characterize the cultures. Explants retained their pancreatic cytoarchitecture for 2 days in vitro. A triphasic dose response to caerulein was detected in 7-day primary cultures. The maximal rate of secretion was 1.2-fold versus basal (p=0.009) and 1.7-fold versus 1 pM caerulein (p=0.014). In secondary cultures the response was biphasic with maximal rates of secretion being 1.9-fold in 3- to 4-day cultures at 0.01 nM (p=0.049) and 2-fold in 6- to 7-day cultures at 0.1 nM (p=0.003). The present culture model provides a means to obtain functionally competent normal mouse acinar cells for long-term in vitro experimentation.
Copyright © 2011 Elsevier GmbH. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21906833     DOI: 10.1016/j.ejcb.2011.07.004

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  8 in total

Review 1.  Concise reviews: In vitro-produced pancreas organogenesis models in three dimensions: self-organization from few stem cells or progenitors.

Authors:  Chiara Greggio; Filippo De Franceschi; Anne Grapin-Botton
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

2.  Mimicking and Manipulating Pancreatic Acinar-to-Ductal Metaplasia in 3-dimensional Cell Culture.

Authors:  Alicia K Fleming Martinez; Peter Storz
Journal:  J Vis Exp       Date:  2019-02-11       Impact factor: 1.355

3.  Calcium imaging in intact mouse acinar cells in acute pancreas tissue slices.

Authors:  Urška Marolt; Eva Paradiž Leitgeb; Viljem Pohorec; Saška Lipovšek; Viktória Venglovecz; Eleonóra Gál; Attila Ébert; István Menyhárt; Stojan Potrč; Marko Gosak; Jurij Dolenšek; Andraž Stožer
Journal:  PLoS One       Date:  2022-06-03       Impact factor: 3.752

Review 4.  Three-dimensional pancreas organogenesis models.

Authors:  A Grapin-Botton
Journal:  Diabetes Obes Metab       Date:  2016-09       Impact factor: 6.577

5.  Isolation and culture of mouse primary pancreatic acinar cells.

Authors:  Johann Gout; Roxane M Pommier; David F Vincent; Bastien Kaniewski; Sylvie Martel; Ulrich Valcourt; Laurent Bartholin
Journal:  J Vis Exp       Date:  2013-08-13       Impact factor: 1.355

6.  Acinar phenotype is preserved in human exocrine pancreas cells cultured at low temperature: implications for lineage-tracing of β-cell neogenesis.

Authors:  Josué K Mfopou; Isabelle Houbracken; Elke Wauters; Iris Mathijs; Imane Song; Eddy Himpe; Jonathan Baldan; Harry Heimberg; Luc Bouwens
Journal:  Biosci Rep       Date:  2016-05-06       Impact factor: 3.840

7.  Characterization of myelomonocytoid progenitor cells with mesenchymal differentiation potential obtained by outgrowth from pancreas explants.

Authors:  Marc-Estienne Roehrich; Giuseppe Vassalli
Journal:  Biotechnol Res Int       Date:  2012-08-21

Review 8.  Organotypic Culture of Acinar Cells for the Study of Pancreatic Cancer Initiation.

Authors:  Carlotta Paoli; Alessandro Carrer
Journal:  Cancers (Basel)       Date:  2020-09-12       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.